APP and Alzheimer disease: We have previously shown that in the APP.PS1 mouse model of AD, perinatal choline supplementation significantly increases β-CTF protein levels in the hippocampus of 12-month-old mice, reminiscent of what is seen in other AD models when treated with a γ-secretase inhibitor [10].